Rinvoq ER 15 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F0MK3
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $21,176
Award facts
- Contract value 100% obligated
- $21,175.70 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $21,175.70 to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-count units) on January 28, 2026, with an ultimate completion date of January 29, 2026. This non-set-aside, firm fixed-price delivery order was issued under a competitive procurement process and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is a major pharmaceutical distributor serving federal medical procurement needs across the defense and veteran healthcare systems.
This delivery order operates under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications, vaccines, medical devices, and specialized healthcare commodities to military treatment facilities and other federal healthcare systems. RINVOQ (upadacitinib), a JAK inhibitor used for rheumatoid arthritis and other autoimmune conditions, represents the type of specialty pharmaceutical products critical to military and veteran healthcare operations that AmerisourceBergen delivers through its federal contract portfolio.
Quick answers
Who was awarded contract SPE2DR26F0MK3?
SPE2DR26F0MK3 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 28, 2026.
How much is contract SPE2DR26F0MK3 worth?
The government has obligated $21,176 on SPE2DR26F0MK3.
Is contract SPE2DR26F0MK3 an order under another contract?
Yes. SPE2DR26F0MK3 is a delivery order under SPE2DR25D3007, an indefinite delivery contract.
Was contract SPE2DR26F0MK3 competed?
The extent of competition for SPE2DR26F0MK3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award